Lucas Gonçalves Mesquita de Oliveira¹*, Karina Mika Kameoka¹, Gustavo de Oliveira Alves Pinto¹, Amanda Lins Bispo Monteiro¹, Marina Luiza Nascimento Rocha¹, Daniela Maria Bastos de Souza2

¹UFRPE; ²DMFA: Departamento de Morfologia e Fisiologia Animal – UFRPE

Objective: To evaluate the in vitro and in vivo results of works already published on the use of traditional and alternative medicines in the treatment of sporotrichosis, both in humans and in animals.

Methods: The bibliographic research was developed from the analysis of publications found in the scientific literature, with emphasis mainly on Brazil in the period from 2015 to 2020. Updated bibliographies of the medical and veterinary literature were available on MEDLINE, through PubMed, Science direct, Scielo and academic Google, with a total of 28 studies that met the specific work requirements.

Results: From the analysis of the reviewed papers, conventional treatments, mainly the use of itraconazole, Amphotericin B and Terbinafine, showed good results in the studies. In addition, the use of alternative treatments, either as the main treatment or support, against sporotrichosis, have shown promise in vitro results, requiring more tests for a possible alternative treatment in the future.

Conclusion: The use of alternative treatments is important, since they can be effective against sporotrichosis, becoming a viable means when the animal is resistant to conventional methods.

Keywords: Sporothrix, Alternative treatments, Antifungal

Free Full-text PDF

How to cite this article:

Lucas Gonçalves Mesquita de Oliveira, Karina Mika Kameoka, Gustavo de Oliveira Alves Pinto, Amanda Lins Bispo Monteiro, Marina Luiza Nascimento Rocha, Daniela Maria Bastos de Souza.TREATMENT OF SPOROTRICOSE IN THE WORLD, WITH EMPHASIS IN BRAZIL: WHAT’S NEW?.International Journal of Traditional and Complementary Medicine 2021, 6:36. DOI: 10.28933/ijtcm-2021-06-1805


1. Fuentes DLP, Batista-Duharte A, Ferreira LS, Martínez DT, Polesi MC, Duarte RA, et al. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection. Immunobiology [Internet]. 2016;221[2]:300–9.
2. Orofino-Costa R, Rodrigues AM, de Macedo PM, Bernardes-Engemann AR. Sporotrichosis: An update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92[5]:606–20.
3. Gremião IDF, Miranda LHM, Reis EG, Rodrigues AM, Pereira SA. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017;13[1]:2–8.
4. Almeida P, Giordano C. Vigilância e cenário epidemiológico: esporotricose no estado do RJ. Bol Epidemiológico Esporotricose. 2018;001:1–6.
5. Giordano C, Almeida P, Santana A, Inês M. Cenário epidemiológico: esporotricose no estado do RJ. Bol Epidemiológico Arboviroses [Internet]. 2019;001:1–6.
6. Gonçalves JC, Gremião IDF, Kolling G, Duval AE de A, Ribeiro PMT. Esporotricose, o gato e a comunidade. Cent cientÍífico Conhecer. 2019;16[29]:769–87.
7. Schubach TM, Menezes RC, Wanke B. Esporotricose. In: Doenças Infeciosas em cães e gatos. 2015. p. 678–84.
8. De Souza EW, De Moraes Borba C, Pereira SA, Gremião IDF, Langohr IM, Oliveira MME, et al. Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix schenckii . Sci Rep. 2018;8[1]:1–10.
9. Rosa CS da, Meinerz ARM, Osório LDG, Cleff MB, Meireles MCA. Terapêutica Da Esporotricose: Revisão. Sci Anim Heal. 2018;5[3]:212.
10. Waller SB, Cleff MB, Serra EF, Silva AL, Gomes A dos R, de Mello JRB, et al. Plants from Lamiaceae family as source of antifungal molecules in humane and veterinary medicine. Microb Pathog [Internet]. 2017;104:232–7.
11. Waller SB, Madrid IM, Hoffmann JF, Picoli T, Cleff MB, Chaves FC, et al. Chemical composition and cytotoxicity of extracts of marjoram and rosemary and their activity against Sporothrix schenckii . J Med Microbiol. 2017;66[7]:1076–83.
12. Waller SB, Madrid IM, Serra EF, Dos Reis Gomes A, Cleff MB, De Faria RO. In vitro susceptibility of the Sporothrix schenckii to aqueous extracts of the green tea [Camellia sinensis L. Kuntze]. Acta Vet Bras. 2015;9[4]:342–7.
13. Waller SB, Peter CM, Hoffmann JF, Picoli T, Osório L da G, Chaves F, et al. Chemical and cytotoxic analyses of brown Brazilian propolis [Apis mellifera] and its in vitro activity against itraconazole-resistant Sporothrix schenckii . Microb Pathog [Internet]. 2017;105:117–21.
14. Oliveira AH, de Oliveira GG, Carnevale Neto F, Portuondo DF, Batista-Duharte A, Carlos IZ. Anti-inflammatory activity of Vismia guianensis [Aubl.] Pers. extracts and antifungal activity against Sporothrix schenckii. J Ethnopharmacol [Internet]. 2016;195:266. 0
15. Burian JP, Sacramento LVS, Carlos IZ. Controle da infecção fúngica pelos extratos de alho [Allium sativum L.] e modulação da atividade de macrófagos peritoneais em modelo murino de esporotricose. Brazilian J Biol. 2017;77[4]:848–55.
16. Waller SB, Madrid IM, Ferraz V, Picoli T, Cleff MB, de Faria RO, et al. Cytotoxicity and anti-Sporothrix schenckii activity of the Origanum majorana Linn. oil. Brazilian J Microbiol [Internet]. 2016;47[4]:896–901.
17. Waller SB, Madrid IM, Cleff MB, Santin R, Freitag RA. Effects of essential oils of Rosmarinus officinalis Linn. and Origanum vulgare Linn. from different origins on Sporothrix schenckii and Sporothrix schenckii complex. Arq Bras Med Veterinária e Zootec. 2016;68[4]:991–9.
18. Portuondo DL, Batista-Duharte A, Ferreira LS, de Andrade CR, Quinello C, Téllez-Martínez D, et al. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either MontanideTM Pet Gel A or aluminum hydroxide adjuvants in mice. Vaccine [Internet]. 2017;35[34]:4430–6.
19. Borba-santos LP, Nucci M, Ferreira-Pereira A, Rozental S. Anti- Sporothrix activity of ibuprofen combined with antifungal. Soc Bras Microbiol. 2020;1–7.
20. Poester VR, Mattei AS, Mendes JF, Klafke GB, Ramis IB, Sanchotene KO, et al. Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix schenckii . Med Mycol. 2019;57[3]:328–31.
21. Gagini T, Borba-Santos LP, Rodrigues AM, de Camargo ZP, Rozental S. Clotrimazole is highly effective in vitro against feline Sporothrix schenckii isolates. J Med Microbiol. 2017;66[11]:1573–80.
22. Garcia LGS, de Melo Guedes GM, Fonseca XMQC, Pereira-Neto WA, Castelo-Branco DSCM, Sidrim JJC, et al. Antifungal activity of different molecular weight chitosans against planktonic cells and biofilm of Sporothrix schenckii . Int J Biol Macromol [Internet]. 2020;143:341–8.
23. Brilhante RSN, Silva MLQ Da, Pereira VS, De Oliveira JS, Maciel JM, Silva ING Da, et al. Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms. Med Mycol. 2019;57[6]:464–72.
24. Asquith CRM, Machado ACS, de Miranda LHM, Konstantinova LS, Almeida-Paes R, Rakitin OA, et al. Synthesis and identification of pentathiepin-based inhibitors of Sporothrix schenckii . Antibiotics. 2019;8[4]:1–12.
25. Garcia Ferreira P, Pereira Borba-Santos L, Noronha LL, Deckman Nicoletti C, de Sá Haddad Queiroz M, de Carvalho da Silva F, et al. Synthesis, Stability Studies, and Antifungal Evaluation of Substituted α- and β-2,3-Dihydrofuranaphthoquinones against Sporothrix schenckii and Sporothrix schenckii. Molecules. 2019;24[5].
26. de Almeida JRF, Santiago KL, Kaihami GH, Maranhão AQ, Brígido M de M, de Almeida SR. The efficacy of humanized antibody against the Sporothrix antigen, gp70, in promoting phagocytosis and reducing disease burden. Front Microbiol. 2017;8[MAR]:1–9.


Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).

This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.